Related Experiment Videos

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

Amir Arastehfar1, Toni Gabaldón2,3,4, Rocio Garcia-Rubio1

  • 1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ 07110, USA.

Insights

Antifungal drug resistance is increasing in invasive fungal infections (IFIs) and agriculture, driven by various factors. Strategies like stewardship programs and new drug development are crucial to combat resistant fungi.

Area of Science:

  • Medical Mycology
  • Antimicrobial Resistance
  • Drug Discovery

Background:

  • Invasive fungal infections (IFIs) cause high mortality and economic losses.
  • Widespread antifungal agent use has led to increased drug resistance in fungi.
  • Limited systemic antifungal drugs face challenges from fungal, host, and drug-related factors.

Purpose of the Study:

  • To review the current landscape of antifungal resistance in clinical and agricultural settings.
  • To discuss the mechanisms and contributing factors to antifungal resistance.
  • To highlight strategies for mitigating antifungal resistance and managing IFIs.

Main Methods:

  • Literature review of antifungal resistance trends.
  • Analysis of factors contributing to resistance.
  • Evaluation of current and future management strategies.

Main Results:

  • Significant antifungal resistance observed in Candida, Aspergillus, Cryptococcus, and Pneumocystis species.
  • Environmental drug-resistant fungi are increasingly found in clinical settings.
  • Limited understanding of resistance mechanisms in emerging Candida species.

Conclusions:

  • Antifungal stewardship programs and susceptibility testing are vital to minimize resistance.
  • New antifungal drugs and adjuvants are needed to treat resistant infections.
  • Addressing antifungal tolerance is key to preventing resistance emergence.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
270
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
829
Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
698
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
660
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
Overview of Fungi01:29

Overview of Fungi

Fungi are a diverse group of eukaryotes more closely related to animals than other eukaryotes. Fungal cell walls comprise chitin, a polysaccharide that provides structural strength, and glucans, which contribute to flexibility and integrity. Other polysaccharides, such as mannans and galactosans, may supplement or replace chitin in some fungi. These adaptations, along with their preference for acidic environments and tolerance for high osmotic pressure, enable fungi to thrive in various...
972